Home › Endometrial Cancer › Kentucky › Lexington
Endometrial Cancer clinical trials in Lexington, KY
5 studies for Endometrial Cancer are looking for participants at sites in and around Lexington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RecruitingPhase 2
- CommonSpirit Saint Joseph Medical Center - East Lexington, Lexington
- University of Kentucky/Markey Cancer Center, Lexington
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
RecruitingPhase 3
- Baptist Health Lexington, Lexington
- University of Kentucky/Markey Cancer Center, Lexington
First in Human Study of TORL-1-23 in Participants With Advanced Cancer
RecruitingPhase 1
- University of Kentucky Medical Center, Lexington
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
RecruitingObservational studyHealthy volunteers welcome
- Baptist Lexington, Lexington
MCC-24-GYN-11: Comparison of Nodal Sampling in Endometrial Cancer
Recruiting
- University of Kentucky, Lexington
Endometrial Cancer trials in other cities
- Houston, TX68 studies
- New York City, NY52 studies
- Boston, MA50 studies
- Arlington, VA39 studies
- Nashville, TN38 studies
- Los Angeles, CA34 studies
- St. Louis, MO29 studies
- Philadelphia, PA28 studies
- San Antonio, TX27 studies
- Chicago, IL25 studies
- Columbus, OH25 studies
- Queens, NY25 studies
Other studies in Lexington
- Non-Small Cell Lung Cancer23 studies
- Lung Cancer18 studies
- Ovarian Cancer16 studies
- Cancer (all types)14 studies
- Prostate Cancer14 studies
- Breast Cancer14 studies
- Metastatic Cancer11 studies
- Heart Failure11 studies
- Colorectal Cancer11 studies
- Obesity10 studies
- Acute Myeloid Leukemia10 studies
- Melanoma10 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.